PRME
NASDAQStockPrime Medicine, Inc.
$3.67-0.07 (-1.74%)
52-Week Range
$1.15
$6.67
Key Stats
Market Cap
661.6M
P/E Ratio
—
Dividend Yield
—
Beta
2.58
Volume
1.5M
Avg Volume
3.4M
Performance
1M
+12.35%
3M
-7.67%
6M
-6.98%
YTD
+5.67%
1Y
+108.38%
3Y
-71.26%
5Y
-76.33%
Price Chart
ETF Exposure
PRME is held by 80 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ARKG | ARK Genomic Revolution ETF | 1.70% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.70% |
| GNOG.L | Global X - Genomics & Biotechnology UCITS ETF | 0.31% |
| GNOM.L | Global X - Genomics & Biotechnology UCITS ETF | 0.31% |
| GNOM | Global X - Genomics & Biotechnology ETF | 0.27% |
| CURE.AX | Global X - S&P Biotech ETF | 0.15% |
| XBI | State Street SPDR S&P Biotech ETF | 0.15% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.14% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 0.13% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.09% |
| IWC | iShares Micro-Cap ETF | 0.08% |
| DBPG.DE | Xtrackers S&P 500 2x Leveraged Daily Swap UCITS ETF 1C | 0.06% |
| XS2D.L | Xtrackers S&P 500 2x Leveraged Daily Swap UCITS ETF 1C | 0.06% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.05% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.05% |
| GINN | Goldman Sachs Innovate Equity ETF | 0.05% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.04% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.03% |
| IBB | iShares Biotechnology ETF | 0.03% |
| PWS | Pacer WealthShield ETF | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.03% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.03% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.01% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.01% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.01% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.01% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| WDSC.L | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| WOSC.L | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| ZPRS.DE | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| ZPRV.DE | State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.00% |
| IMID.L | State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc) | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
Page 1 of 2Next
About PRME ETF Exposure
Prime Medicine, Inc. (PRME) is held by 80 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 661.6M, PRME is a widely held institutional stock. The stock currently trades at $3.67. Investors can gain exposure to PRME through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PRME, sorted by portfolio weight.